| 000 | 01105 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250516233054.0 | ||
| 264 | 0 | _c20150402 | |
| 008 | 201504s 0 0 eng d | ||
| 022 | _a1473-2262 | ||
| 024 | 7 |
_a10.22203/ecm.v028a09 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMoriarty, T F | |
| 245 | 0 | 0 |
_aChallenges in linking preclinical anti-microbial research strategies with clinical outcomes for device-associated infections. _h[electronic resource] |
| 260 |
_bEuropean cells & materials _cSep 2014 |
||
| 300 |
_a112-28; discussion 128 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aDrug Evaluation, Preclinical _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aProsthesis-Related Infections _xdrug therapy |
| 700 | 1 | _aGrainger, D W | |
| 700 | 1 | _aRichards, R G | |
| 773 | 0 |
_tEuropean cells & materials _gvol. 28 _gp. 112-28; discussion 128 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.22203/ecm.v028a09 _zAvailable from publisher's website |
| 999 |
_c24183816 _d24183816 |
||